Xiang-Bin Chen

Xiang-Bin Chen

Auto-generated profile, based on publicly available information

Xiang-Bin Chen

The Second Clinical School of Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510720, PR China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2025 in Phytomedicine
Verified
Journal Article
Closed access
XWXiao-Yu Wei
Xiao-Yu Wei
FXFu-Ping Xu
Fu-Ping Xu
XCXiang-Bin Chen
Xiang-Bin Chen
QXQing Xu
Qing Xu
LDLu-Yao Deng
Lu-Yao Deng
ZYZhimin Yang
Zhimin Yang

14 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
YKYu Kaijing
Yu Kaijing
KYKai-Jing Yu
Kai-Jing Yu
GYGui-Zhi Yang
Gui-Zhi Yang
JHJuan Huang
Juan Huang
TFTan Fei
Tan Fei
WXWen Xu
Wen Xu
Ethnopharmacological relevance: Yiqi Yangxin Anshen Oral Liquid (YQYX) is a multi-herbs compound derived from the ancient Chinese formulae Suanzaoren Decoction and Guipi Tang. It has been clinically using to treat insomnia and anxiety near three decades.Aim of the study: To evaluate the efficacy of YQYX and to elucidate its therapeutic mechanisms in mitigating pathological changes caused by sleep deprivation (SD). Methods: Chemical constituents and serum-absorbed components were characterized by UHPLC-Orbitrap-MS. Network pharmacology predicted therapeutic targets. PCPA-induced SD rats underwent pentobarbital-induced sleep test, Morris water maze, and open field test. Serum inflammatory cytokines were measured by ELISA, hypothalamic neurotransmitters by a validated UHPLC-QQQ-MS/MS method. hippocampal damage was evaluated by H&E and NeuN immunofluorescence, and cAMP/PKA/CREB/BDNF pathway was studied by Western blot. Results: LC-MS identified 102 chemical constituents and 49 serum-absorbed components in YQYX. Network pharmacology analysis based on the serum-absorbed components predicted the cAMP signaling pathway as a key therapeutic target. YQYX significantly ameliorated SD-induced sleeplessness effects, spatial learning-memory impairment, and anxiety-like behaviors. YQYX mitigated inflammation by reducing serum levels of IL-1β, TNF-α, and IL-6. Notably, YQYX restored hypothalamic neurotransmitters homeostasis (serotonin, dopamine, histamine, and acetylcholine). Histological analysis showed that YQYX prevented SD-induced hippocampal damage in CA1 and CA3 regions. Moreall, YQYX could upregulate the cAMP/PKA/CREB/BDNF signaling pathway.Conclusion: YQYX exhibits multi-target therapeutic effects through neurotransmitter homeostasis, anti-neuroinflammation, hippocampal neuroprotection, and neuroplasticity pathway activation, validating its ethnopharmacological basis for treating sleep disorders.

7 February 2023 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
XLXixue Lu
Xixue Lu
XCXiangbin Chen
Xiangbin Chen
YZYupu Zhai
Yupu Zhai
XSXiangyu Sun
Xiangyu Sun
JXJiakun Xu
Jiakun Xu
ZWZhibing Wu
Zhibing Wu